MILANO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.482
AS - Asia 943
EU - Europa 731
SA - Sud America 174
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 24
OC - Oceania 1
Totale 3.477
Nazione #
US - Stati Uniti d'America 1.401
SG - Singapore 405
IT - Italia 248
IE - Irlanda 159
CN - Cina 142
HK - Hong Kong 141
BR - Brasile 127
VN - Vietnam 114
RU - Federazione Russa 106
FR - Francia 53
CA - Canada 31
DE - Germania 28
FI - Finlandia 27
KR - Corea 21
TR - Turchia 21
AR - Argentina 20
BD - Bangladesh 19
IQ - Iraq 18
GB - Regno Unito 17
SE - Svezia 15
PL - Polonia 13
MX - Messico 12
UA - Ucraina 12
ID - Indonesia 11
IN - India 10
ZA - Sudafrica 10
AT - Austria 9
CR - Costa Rica 8
ES - Italia 7
JP - Giappone 7
LT - Lituania 7
NL - Olanda 7
PH - Filippine 7
CO - Colombia 6
GT - Guatemala 6
JM - Giamaica 6
VE - Venezuela 6
BE - Belgio 5
EC - Ecuador 5
NI - Nicaragua 5
PE - Perù 5
CW - ???statistics.table.value.countryCode.CW??? 4
SA - Arabia Saudita 4
UY - Uruguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EU - Europa 3
IL - Israele 3
SC - Seychelles 3
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
MA - Marocco 2
PK - Pakistan 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
Totale 3.362
Città #
Singapore 303
San Jose 182
Dublin 158
Hong Kong 141
Chandler 135
Ashburn 134
Perugia 95
San Mateo 74
Santa Clara 65
Council Bluffs 49
Dong Ket 47
Boardman 46
Beijing 35
Dallas 32
Lauterbourg 31
Medford 29
Moscow 29
Princeton 28
Lawrence 26
Pisa 26
Ho Chi Minh City 23
Los Angeles 23
New York 22
Seoul 21
São Paulo 18
Redmond 17
Wilmington 17
Altamura 16
Des Moines 16
Hanoi 16
Munich 15
Rome 15
Turku 15
Andover 14
Atlanta 9
Brooklyn 9
Montreal 9
North Bergen 9
Piscataway 9
Baghdad 8
Helsinki 8
Orem 8
Phoenix 8
Saint Petersburg 8
San José 8
San Paolo di Civitate 8
The Dalles 8
Warsaw 8
Denver 7
Izmir 7
Manila 7
Tokyo 7
Ankara 6
Florence 6
Jakarta 6
Mexico City 6
Rio de Janeiro 6
Toronto 6
Vienna 6
Belo Horizonte 5
Brussels 5
Buffalo 5
Guatemala City 5
Houston 5
Managua 5
Norwalk 5
San Francisco 5
Amsterdam 4
Boston 4
Cagliari 4
Collazzone 4
Frankfurt am Main 4
Gualdo Cattaneo 4
Johannesburg 4
Kingston 4
Manchester 4
Milan 4
Recife 4
Vicenza 4
Basra 3
Caracas 3
Charlotte 3
Curitiba 3
Dhaka 3
Edmonton 3
Montevideo 3
Naples 3
Olomouc 3
Tashkent 3
Willemstad 3
Arezzo 2
Bangkok 2
Barnet 2
Buenos Aires 2
Cabo Frio 2
Carandaí 2
Castiglione del Lago 2
Chennai 2
Columbus 2
Contagem 2
Totale 2.241
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 221
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 191
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 148
Mutant NPM1 Maintains the Leukemic State through HOX Expression 142
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 131
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 128
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 127
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 121
Cytokeratin and CDX-2 expression in Barrett's esophagus 118
Current status and future perspectives in targeted therapy of NPM1-mutated AML 109
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 109
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 107
Bone Morphogenetic Protein 4 Expressed in Esophagitis Induces a Columnar Phenotype in Esophageal Squamous Cells 103
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 102
An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes 102
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients 100
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer 95
A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia 92
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations 91
Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens 88
Low level of Her-2 locus amplification by fluorescent in situ hybridization does not correlate with Her-2 protein overexpression by immunohistochemistry in Barrett's esophagus 87
Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population 85
Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia 82
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus 82
Electroporation of dendritic cells with autologous total RNA from tumor material 78
Expression pattern of immune suppressive cytokines and growth factors in oesophageal adenocarcinoma reveal a tumour immune escape-promoting microenvironment 76
Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery 72
Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine 71
A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia 68
Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model 63
Gene expression profile comparison of Barrett's esophagus epithelial cell cultures and biopsies 57
Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response 54
Novel therapeutic strategies for treating esophageal adenocarcinoma: The potential of dendritic cell immunotherapy and combinatorial regimens 50
Omacetaxine mepessucinate plus venetoclax show strong synergistic anti-leukemic activity in nucleophosmin (NPM1)-mutated AML patient-derived xenograft (PDX) models to support a phase 1 clinical trial 42
ISOCITRATE DEHYDROGENASES AML-ASSOCIATED POINT MUTATIONS DRIVE A BLOCK OF DIFFERENTIATION IN HUMAN NORMAL CD34+HEMATOPOIETIC CELLS THAT IS RELEASED BY SPECIFIC INHIBITORS 33
EXTRAMEDULLARY INVOLVEMENT IN PATIENT-DERIVED XENOGRAFT MODELS OF ACUTE MYELOID LEUKEMIA (AML) WITH NUCLEOPHOSMIN (NPM-1) MUTATION 28
A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms 24
Totale 3.477
Categoria #
all - tutte 16.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022171 0 0 0 0 8 0 1 68 3 7 46 38
2022/2023492 27 78 13 19 54 62 1 17 191 6 18 6
2023/2024195 7 23 9 6 3 0 63 0 4 8 34 38
2024/2025588 14 43 22 32 75 30 47 46 111 38 91 39
2025/20261.269 74 87 40 177 178 117 193 62 182 95 42 22
2026/2027396 36 52 88 167 53 0 0 0 0 0 0 0
Totale 3.477